340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

Pro-340B Protesters Picket PhRMA Headquarters

AIDS Healthcare Foundation Activists Wear Pig Noses 

October 22, 2015 -- Chanting “Hey-Hey, ho-ho, pharma greed has got to go!” a group of protesters from the AIDS Healthcare Foundation protested in front of the headquarters building of PhRMA in Washington, DC today.  … [Read more...]

HRSA Proposes Changes to 340B Pharmaceutical Pricing Agreement

Collecting public comments until December 21, 2015 

October 21, 2015 - The Health Resources and Services Administration is seeking public comments about proposed changes to the current Pharmaceutical Pricing Agreement (PPA). … [Read more...]

Court Rules in PhRMA’s Favor on Orphan Drugs

Rejects government argument on using 340B pricing for common disease indications 

A federal court today soundly rejected the Department of Health and Human Service’s interpretation of the 340B statute’s orphan drug exclusion as it relates to providers added to the program in the Affordable Care Act in 2010. The ruling means that rural and cancer hospitals will no longer be able to get 340B pricing on any orphan drug. … [Read more...]

Second Generic Drugmaker in a Month Acknowledges 340B Overcharges

Zydus, like Heritage before it, is under investigation for price increases 

October 6, 2015—For the second time in less than a month, a generic-drug manufacturer under congressional investigation for price increases has announced that it owes 340B covered entities refunds due to overcharges. … [Read more...]

340B Comes Up During Two Congressional Hearings

Questions asked about program's possible effects on Medicare and private cancer clinics 

October 1, 2015—Questions about whether hospitals' 340B drug discounts might be costing Medicare more and harming private cancer clinics were asked at two hearings on Capitol Hill this morning. … [Read more...]

Drug Industry Complimentary of Proposed Rules

AIR 340B urges HRSA to be more assertive toward providers 

September 30, 2015—The Health Resources and Services Administration’s proposed 340B mega-guidance is an "encouraging first step" toward reform, says the drug-industry-led group AIR 340B in a new communiqué. … [Read more...]

Congress Wants Drug Makers to Explain Price Increases

Lawmakers call Valeant CEO to appear alongside Turing CEO at hearing 

September 29, 2015—Eighteen members of the House Oversight and Government Reform Committee have asked Chairman Jason Chaffetz (R-Utah) to “issue a subpoena compelling Valeant Pharmaceuticals to turn over documents the company is withholding from Congress relating to massive price increases earlier this year for two drugs used by hospitals and other providers to treat serious … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health